MassDevice.com +5 | The top 5 medtech stories for July 3, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. BD extends Bard note exchange offering again Becton Dickinson said today is once again extending its exchange offering for up to $1.1 billion in outstanding C. R. Bard notes from July 3 to August 1. The company is offering exchanges for approximately $500 million for 4.4% Bard note due 2021, $500 million for 3% notes due 2026 and $149.8 million in 6.7% notes due 2026. Read more 4. Abbott wins Health Canada nod for FreeStyle Libre glucose monitor Abbott said today that its FreeStyle Libre glucose monitoring system won Health Canada approval for adults with diabetes. The company’s disposable glucose monitoring device is worn on the back of the upper arm and senses glucose using a small filament that is placed under the skin. Every scan includes a real-time glucose reading, as well as an 8-hour snapshot of blood sugar data. Read more 3. Second Sight Medical wins expanded CMS coverage for Argus II Second Sight Medical said today its Argus II retinal prosthesis system won expanded reimbursement coverage from the Centers for Medicare and Medicaid Services in 11 additio...
Source: Mass Device - Category: Medical Devices Authors: Tags: News Well Plus 5 Source Type: news